Press release
Investigation announced for Investors in shares of Hanmi Financial Corporation (NASDAQ: HAFC)
An investigation for investors in Hanmi Financial Corporation (NASDAQ: HAFC) shares over potential securities laws violations.
Investors who purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Hanmi Financial Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Los Angeles, CA based Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides business banking products and services in the United States. Hanmi Financial Corporation reported that its annual Total Revenue declined from $210.21 million in 2017 to $205.53 million in 2018 and that its Net Income increased from $54.32 million in 2017 to $57.5 million in 2018.
On January 28, 2020, Hanmi Financial Corporation announced its financial results for the 2019 fiscal fourth quarter. Therein, Hanmi Financial Corporation reported net income of $3.1 million for fourth quarter 2019, which included "a $6.9 million specific provision for loan and lease losses related to [a] previously identified $39.7 million troubled loan relationship." According to Hanmi's President and Chief Executive Officer Bonnie Lee, "[w]ith the loans comprising this relationship maturing on December 31, 2019, [Hanmi] received current appraisals on the personal property securing the relationship and ha[s] provided for a specific allowance at the lower range of the appraised values."
Shares of Hanmi Financial Corporation (NASDAQ: HAFC) declined from $20.79 per share on December 20, 2019 to as low as $16.30 per share on January 29, 2020.
On February 5, 2020, NASDAQ: HAFC shares closed at $17.85 per share.
Those who purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Hanmi Financial Corporation (NASDAQ: HAFC) here
News-ID: 1920734 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Hanmi
Short Bowel Syndrome Market to Experience Notable Growth in Forecast Span by 203 …
The Key Short Bowel Syndrome Companie in the market inlcude - Zealand Pharma, Ironwood Pharmaceuticals, Hanmi Pharmaceutical, Shire, AbbVie, Hanmi Pharma, EMD Serono, Zealand Pharma, VectivBio AG, Baxter Healthcare, and others.
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain,…
Short Bowel Syndrome Market Growth Projections 2024-2034: DelveInsight Analysis …
The Key Short Bowel Syndrome Companies in the market include - Zealand Pharma, Ironwood Pharmaceuticals, Hanmi Pharmaceutical, Shire, AbbVie, Hanmi Pharma, EMD Serono, Zealand Pharma, VectivBio AG, Baxter Healthcare, and others.
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain,…
Short Bowel Syndrome Market to Show Remarkable Growth Trends from 2024 to 2034, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Short Bowel Syndrome Market Report 2032: Epidemiology Data, Pipeline Therapies, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Short Bowel Syndrome Market Report 2032: Epidemiology Data, Pipeline Therapies, …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as well as the Short Bowel Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Short Bowel Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Short Bowel Syndrome…
Investigation announced for Long-Term Investors in Hanmi Financial Corporation ( …
An investigation on was announced over potential breaches of fiduciary duties by certain directors at Hanmi Financial Corporation .
Investors who purchased shares of Hanmi Financial Corporation (NASDAQ: HAFC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Hanmi Financial directors breached their fiduciary duties and caused damage to the company and its shareholders.
On March…
